Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02835339 · ClinicalTrials.gov registry record · Phase 4
Magnesium Sulfate in Obese Preeclamptics
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 66
- Enrollment target
NCT02835339 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 66 participants.
The verdict
NCT02835339, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to learn how medications participant will receive in the course of their delivery are metabolized (broken down by the body). The investigators hope to learn more about the way drugs are metabolized by pregnant women, and how those drugs are distributed in the blood and body compartments and cleared in the urine, and how maternal body weight affects the metabolism. With this information the investigators will be able to develop a treatment regimen considering factors in the body that affect magnesium levels so that the investigators can improve treatment of pregnant women. The goal of the study is to understand how different dosing of magnesium sulfate affects blood levels of the magnesium in larger women.
Interventions
- DRUG Magnesium sulfate 4g loading dose, 1g/hr infusion
- DRUG Magnesium sulfate 6g loading dose, 2g/hr infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2016-07-12 |
| Est. Completion | 2019-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02835339
The ClinicalTrials.gov registry entry for NCT02835339 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magnesium sulfate 4g loading dose, 1g/hr infusion is the first listed.
NCT02835339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02835339 about?
NCT02835339 is a clinical study titled "Magnesium Sulfate in Obese Preeclamptics". The purpose of this study is to learn how medications participant will receive in the course of their delivery are metabolized (broken down by the body). The investigators hope to learn more about the way drugs are metabolized by pregnant women, and how those drugs are distributed in the blood and b...
What is the current status of trial NCT02835339?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 2016-07-12. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT02835339?
The interventions under investigation include: Magnesium sulfate 4g loading dose, 1g/hr infusion (DRUG), Magnesium sulfate 6g loading dose, 2g/hr infusion (DRUG).
Who is sponsoring clinical trial NCT02835339?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.